Evropska unija - angleščina - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.

Evropska unija - angleščina - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Singapur - angleščina - HSA (Health Sciences Authority)

princeton pharmacy (s) private limited - ophthalmology - for chemical splash on eyes and skin, removal of foreign particles, mucous secretions and fluorescein dye used in diagnosis.

Kanada - angleščina - Health Canada

princess auto ltd. - sodium hypochlorite - solution - 7.20% - sodium hypochlorite 7.20% - disinfectants (for agents used on object)

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - princess volume plus lidocaine is a sterile, biodegradable, viscoelastic, clear, transparent, isotonic and homogenized injectable gel implant. the device is intended for single use, it is non-active and without measuring function. a drug substance (lidocaine hydrochloride) is integrated into the device. the ancillary role of lidocaine hydrochloride is to reduce the pain associated with injections into the patient. the intended purpose of the device is to restore facial volume in order to correct moderate to severe midface volume deficit to treat signs of ageing.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 59131 - dermal tissue reconstructive material, microbe-derived - a sterile, biodegradable, viscoelastic, clear, colourless, isotonic and homogenized injectable gel implant. it consists of cross-linked hyaluronic acid, formulated to a concentration of 23 mg/ml in a physiologic buffer. princess filler is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) and to increase lip volume.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 59131 - dermal tissue reconstructive material, microbe-derived - a sterile, viscoelastic, clear, colourless, transparent, isotonic, biodegradable and injectable gel composed of hyaluronate. princess rich is a viscoelastic solution to replenish the loss of hyaluronic acid due to ageing. it is designed to be injected into the superficial dermal tissue, preferably deeper, to improve tone and elasticity of the skin.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 59131 - dermal tissue reconstructive material, microbe-derived - a sterile, biodegradable, viscoelastic, clear, colourless, isotonic and homogenized, injectable gel. it consists of cross-linked hyaluronic acid formulated to a concentration of 23 mg/ ml in a physiologic buffer. princess volume is an injectable biodegradable gel to increase or restore volume of the face, remodel facial contours and correct deeper wrinkles and folds; it is indicated for injection into the deep dermis, subcutis or supraperiosteally.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

goyescas of fla - undecylenic acid (unii: k3d86kj24n) (undecylenic acid - unii:k3d86kj24n) - undecylenic acid 100 mg in 1 ml - uses: for the treatment of athletes foot, jock itch and other fungal infections. for relief of itching burning irritation and discomfort which may accompany these conditions. drug facts: purpose undecylenic acid 10% antifungal

Združene države Amerike - angleščina - NLM (National Library of Medicine)

goyescas of fla - drug facts:, active ingredients: purpose, undecylenic acid 10% antifungal - uses: for the treatment of athletes foot, jock itch and other fungal infections. for relief of itching burning irritation and discomfort which may accompany these conditions. drug facts: purpose undecylenic acid 10% antifungal